Specifically, EIF1 (OR: 1.404; CI: 1.069–1.844; p = 0.015) and RPS12 (OR: 1.177; CI: 1.016–1.363; p = 0.030) were associated with an increased risk of GC. This evidence concerns the gene EIF1 and gastric cancer.